10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,360,000 | -37.1% | 750,000 | 0.0% | 100.00% | 0.0% |
| Q2 2022 | $33,938,000 | -40.5% | 750,000 | 0.0% | 100.00% | +0.3% |
| Q1 2022 | $57,053,000 | -48.9% | 750,000 | 0.0% | 99.71% | +0.0% |
| Q4 2021 | $111,720,000 | +2.3% | 750,000 | 0.0% | 99.68% | +16.7% |
| Q3 2021 | $109,185,000 | -25.7% | 750,000 | 0.0% | 85.42% | -3.5% |
| Q2 2021 | $146,865,000 | -18.9% | 750,000 | -25.0% | 88.53% | -3.0% |
| Q1 2021 | $181,000,000 | +2.3% | 1,000,000 | -20.0% | 91.29% | -2.0% |
| Q4 2020 | $177,000,000 | -48.4% | 1,250,000 | -54.5% | 93.12% | -3.5% |
| Q3 2020 | $342,870,000 | +9.7% | 2,750,000 | -21.4% | 96.54% | -2.0% |
| Q2 2020 | $312,585,000 | -13.3% | 3,500,000 | -39.5% | 98.53% | -1.3% |
| Q1 2020 | $360,728,000 | -34.6% | 5,788,317 | -20.0% | 99.80% | -0.1% |
| Q4 2019 | $551,699,000 | – | 7,235,396 | – | 99.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |